B. Karaosmanoğlu Et Al. , "Allele-specific antisense oligonucleotides for the treatment of BEST1-Related dominantly inherited retinal diseases: An in vitro model," EXPERIMENTAL EYE RESEARCH , vol.241, pp.1, 2024
Karaosmanoğlu, B. Et Al. 2024. Allele-specific antisense oligonucleotides for the treatment of BEST1-Related dominantly inherited retinal diseases: An in vitro model. EXPERIMENTAL EYE RESEARCH , vol.241 , 1.
Karaosmanoğlu, B., Imren, G., Utine, E., Sekeroglu, H. T., & Taskiran, E., (2024). Allele-specific antisense oligonucleotides for the treatment of BEST1-Related dominantly inherited retinal diseases: An in vitro model. EXPERIMENTAL EYE RESEARCH , vol.241, 1.
Karaosmanoğlu, BEREN Et Al. "Allele-specific antisense oligonucleotides for the treatment of BEST1-Related dominantly inherited retinal diseases: An in vitro model," EXPERIMENTAL EYE RESEARCH , vol.241, 1, 2024
Karaosmanoğlu, BEREN Et Al. "Allele-specific antisense oligonucleotides for the treatment of BEST1-Related dominantly inherited retinal diseases: An in vitro model." EXPERIMENTAL EYE RESEARCH , vol.241, pp.1, 2024
Karaosmanoğlu, B. Et Al. (2024) . "Allele-specific antisense oligonucleotides for the treatment of BEST1-Related dominantly inherited retinal diseases: An in vitro model." EXPERIMENTAL EYE RESEARCH , vol.241, p.1.
@article{article, author={BEREN KARAOSMANOĞLU Et Al. }, title={Allele-specific antisense oligonucleotides for the treatment of BEST1-Related dominantly inherited retinal diseases: An in vitro model}, journal={EXPERIMENTAL EYE RESEARCH}, year=2024, pages={1} }